TAVNEOS® (avacopan) Update September 24, 2026 VF Requests a Public Hearing with FDA Regarding the Proposed Withdrawal of NDA 214487 Tavneos® (avacopan) U.S. Food and
From Advocacy to Impact: Policy Strategies to Accelerate Rare Disease Cures On February 19, the Vasculitis Foundation hosted a virtual rare disease policy briefing that brought
2025 V-Red Winners The Vasculitis Recognizing Excellence in Diagnosis (V-RED) awards celebrate healthcare providers whose insight, persistence, and compassion have profoundly impacted the lives of
Meet VF Young Investigator Audra Horomanski, MD Early Inspiration and Commitment to Vasculitis Research Dr. Horomanski’s journey into vasculitis research began during her residency and
Research Illuminates Information Needs of Patients with Vasculitis Jodi Hall, Senior Patient Support Associate at the Vasculitis Foundation, recently presented her study, “Information Needs of
Vinay Kamath, 15, Wants More Vasculitis Research So He Started a Fundraiser When Vinay Kamath, 15, found out his grandmother had ANCA negative vasculitis with
Young Adults Connect at Nashville Conference, Offer Hope to One Another Young adults between 18 and 30 came from all across the United States and
Rare Disease Day is All About Sharing Information Get ready to show your support for everyone who has been diagnosed with a rare disease. Rare
Lack of Vasculitis Expertise Leads to Devastating End Karen Miller has joined her local hospital’s patient advisory board after her mother, Lynn Johnston, died from
Late Vasculitis Diagnosis Steals Nearly One Decade Christine Gerchow was in her final semester at Villanova University in 2002 and planning for a promising career,
People living with vasculitis rely on support, research, and connection every day.
Today only, your donation will be matched dollar-for-dollar, helping us reach more patients, fund critical research, and ensure no one faces vasculitis alone.
